• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Sunday 06/24/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Nimbo Tracking

  • IGEN Networks Logo
    4:20 PM

    MURRIETA, Calif., Oct. 31, 2016, IGEN, (GLOBE NEWSWIRE) — Nimbo Tracking, a wholly owned subsidiary of IGEN Networks Corp (the “Company” or “IGEN”) (OTCQB:IGEN) (CSE:IGN), announces it will exhibit at The SEMA Show next week from November 1 to November 4, 2016 at the Las Vegas Convention Center. The SEMA Show is the premier automotive specialty products trade event in the world that attracts more than 100,000 industry leaders from more than 100 countries. Attendees are invited to visit Booth

    Read more
  • 3:07 PM

    SILVER SPRING, Md., April 08, 2016, PMCB, (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today reported that the encapsulation facility located in Bangkok, Thailand, that will be used to encapsulate the live cells used for PharmaCyte’s pancreatic cancer therapy has recently been inspected by the Food and Drug Administration of Thailand (Thai FDA). In its report on that inspection,

    Read more
  • 3:51 PM

    Investors in Final Close Include All Five Board Members SOUTH EASTON, Mass., April 7, 2016, PBIO, /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced the receipt of $769,667 in the final close of its $5 Million PIPE Financing (the “Offering”). This final closing increased the total raised in the Offering to $6,329,667, an

    Read more
  • 3:10 PM

    Jan 12, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical Scan was the highest since the launch of the product. LuViva product revenue was approximately $276,000 for the fourth quarter of 2015 versus approximately $183,000 for the same period of 2014, an increase of about 51%. Total sales for

    Read more
  • 4:21 PM

    GERMANTOWN, MD– ORGS, (Marketwired – Dec 16, 2015) – Orgenesis Inc. (OTCQB: ORGS) (the “Company”), a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient’s own cells into functioning insulin-producing cells as a treatment for diabetes, today announced the company has raised and fulfilled its obligation for a $10 million debt or equity financing and, per a prior agreement, allows Orgenesis to fulfill its obligation and finalize the acquisition of MaSTherCell, an advanced

    Read more
  • 4:05 PM

    Dec 03, 2015, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it shipped the first 10,000 LuViva® Advanced Cervical Scan single-patient-use Cervical Guide disposables for the Turkish Ministry of Health (MOH) contract. The $14 million contract calls for 25 LuViva units and 40,000 disposable Cervical Guides before the end of 2015. Four LuViva units and 10,000 Cervical Guides

    Read more
Public Wire Banner